EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CRISPR/Cas Tools for the Detection of Borrelia sensu lato in Human Samples

Ermanno Nardon, Eros Azzalini iD, Dino Paladin, Diego Boscarino iD, Serena Bonin iD

Genes · 2025

DOI: 10.3390/genes16101233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Ermanno Nardon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences (DSM), University of Trieste, 34149 Trieste, Italy. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Lyme Disease, Borrelia burgdorferi Group. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DOTT, Associazione Lyme Italia e coinfezioni.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Lyme disease diagnosis remains challenging due to the limitations of current methods. While PCR-based assays are widely used, their sensitivity can be affected by sample type and the inhibition of host DNA. This study aimed to evaluate the feasibility and sensitivity of a CRISPR/Cas12-based detection system for Borrelia burgdorferi sensu lato, comparing its performance with real-time PCR.

Methods

DNA from three Borrelia genospecies (B. burgdorferi, B. garinii, and B. afzelii) was amplified targeting the OspA gene. Detection was performed using a Cas12/crRNA system with a fluorescent ssDNA reporter. Sensitivity assays were conducted on serial dilutions of Borrelia DNA, with and without human genomic DNA, and results were compared with qPCR.

Results

Direct detection of Borrelia DNA without amplification was not feasible. However, when combined with PCR, the Cas12/crRNA system reliably detected as few as 5 genome copies per reaction. End-point PCR extended to 60 cycles improved detection robustness for B. garinii and B. afzelii, although sensitivity decreased in the presence of human genomic DNA.

Conclusions

The Cas12/crRNA-based system offers a sensitive and accessible alternative to qPCR, especially in settings lacking real-time PCR instrumentation. Future developments may include integration with isothermal amplification and microfluidic platforms to enhance direct detection capabilities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsLyme DiseaseBorrelia burgdorferi GroupHumansDNA, BacterialReal-Time Polymerase Chain ReactionSensitivity and SpecificityBacterial Outer Membrane ProteinsAntigens, SurfaceBacterial VaccinesLipoproteins

Stichwörter der Autor:innen

BorreliaCas12Lyme diseasePCRdetection

Substanzen

DNA, BacterialOspA proteinBacterial Outer Membrane ProteinsAntigens, SurfaceBacterial VaccinesLipoproteins

Autor:innen und Institutionen

  • Department of Medical Sciences (DSM), University of Trieste, 34149 Trieste, Italy.
  • AB Analitica S.r.l., 35127 Padova, Italy.

ORCID-Profile: Eros Azzalini, Diego Boscarino, Serena Bonin

Förderung

  • DOTT
  • Associazione Lyme Italia e coinfezioni

Zitieren

APA

Nardon, E., Azzalini, E., Paladin, D., Boscarino, D., & Bonin, S. (2025). CRISPR/Cas Tools for the Detection of Borrelia sensu lato in Human Samples. Genes. https://doi.org/10.3390/genes16101233

Vancouver

Nardon E, Azzalini E, Paladin D, Boscarino D, Bonin S. CRISPR/Cas Tools for the Detection of Borrelia sensu lato in Human Samples. Genes. 2025. doi:10.3390/genes16101233

BibTeX
@article{Nardon2025,
  author = {Nardon, Ermanno and Azzalini, Eros and Paladin, Dino and Boscarino, Diego and Bonin, Serena},
  title = {CRISPR/Cas Tools for the Detection of Borrelia sensu lato in Human Samples},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16101233}
}
Kostenlos starten →